ProMIS Neurosciences Inc. is trading 7.2% up today at $9.79 on a speculative rebound following a 6.2% decline on June 5, 2026.
- The price action is currently driven by speculative flows and thin liquidity in the small-cap biotech space, with no fresh company-specific announcements or fundamental news reported.
- Modest gains in broader market indices are likely providing marginal support for the stock as it continues to trade within a highly volatile range.